• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神病学中ω-3脂肪酸的应用:基于证据还是基于理论?

Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?

作者信息

Naguy Ahmed

机构信息

a Kuwait Centre for Mental Health , Al-Manara CAP Centre , Shuwaikh , Kuwait.

出版信息

J Diet Suppl. 2018 Jan 2;15(1):124-128. doi: 10.1080/19390211.2017.1326432. Epub 2017 May 30.

DOI:10.1080/19390211.2017.1326432
PMID:28558251
Abstract

Use of omega-3 in psychiatric practice is on the rise. It has been used in diverse indications, notably mood disorders, schizophrenia, dementia, borderline personality, and neurodevelopmental disorders, with varying levels of evidence base. Here, the author sheds some light on the therapeutic potential of omega-3 as an appealing addition to psychopharmacological armamentarium.

摘要

ω-3在精神科实践中的应用正在增加。它已被用于多种适应症,尤其是情绪障碍、精神分裂症、痴呆、边缘型人格障碍和神经发育障碍,证据基础水平各不相同。在此,作者阐明了ω-3作为精神药理学武器库中一种有吸引力的补充药物的治疗潜力。

相似文献

1
Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?精神病学中ω-3脂肪酸的应用:基于证据还是基于理论?
J Diet Suppl. 2018 Jan 2;15(1):124-128. doi: 10.1080/19390211.2017.1326432. Epub 2017 May 30.
2
Omega-3 fatty acids in psychiatry: a review.精神病学中的Omega-3脂肪酸:综述
Ann Clin Psychiatry. 2000 Sep;12(3):159-65. doi: 10.1023/a:1009069002816.
3
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.ω-3脂肪酸:精神病学治疗及未来研究的证据基础
J Clin Psychiatry. 2006 Dec;67(12):1954-67. doi: 10.4088/jcp.v67n1217.
4
Psychopharmacology of borderline personality disorder.边缘型人格障碍的精神药理学
Curr Psychiatry Rep. 2004 Jun;6(3):225-31. doi: 10.1007/s11920-004-0068-y.
5
Psychopharmacology in child and adolescent psychiatry: a review of the past five years.儿童与青少年精神病学中的精神药理学:过去五年综述
J Am Acad Child Adolesc Psychiatry. 1988 May;27(3):269-79. doi: 10.1097/00004583-198805000-00001.
6
Randomized placebo-controlled trials of omega-3 polyunsaturated fatty acids in psychiatric disorders: a review of the current literature.ω-3多不饱和脂肪酸在精神疾病中的随机安慰剂对照试验:当前文献综述
Curr Drug Discov Technol. 2013 Sep;10(3):245-53. doi: 10.2174/1570163811310030007.
7
Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?多不饱和脂肪酸:它们在治疗精神疾病方面的作用是什么?
Int J Mol Sci. 2019 Oct 23;20(21):5257. doi: 10.3390/ijms20215257.
8
[Psychopharmacological treatment: patients' knowledge about their medication].
Recenti Prog Med. 2003 Sep;94(9):387-90.
9
Are mood stabilisers helpful in treatment of borderline personality disorder?心境稳定剂对边缘型人格障碍的治疗有帮助吗?
BMJ. 2014 Sep 16;349:g5378. doi: 10.1136/bmj.g5378.
10
[The borderline concept: therapeutic implications].[边缘概念:治疗意义]
Encephale. 1998 Jul;24 Spec No 1:4-7.

引用本文的文献

1
Borderline Personality Disorder and Self-Injurious Behaviours- Psychopharmacological Considerations.边缘型人格障碍与自我伤害行为——心理药理学考量
Psychopharmacol Bull. 2025 Feb 3;55(2):75-79.
2
Treatment-Resistant Juvenile Depression-A Quicksand?治疗抵抗性青少年抑郁症——一片泥沼?
Psychopharmacol Bull. 2023 Dec 4;53(4):54-56.
3
Novel Pharmacological Targets for Combat PTSD-Metabolism, Inflammation, The Gut Microbiome, and Mitochondrial Dysfunction.对抗创伤后应激障碍的新型药理学靶点——代谢、炎症、肠道微生物群和线粒体功能障碍
Mil Med. 2020 Jan 7;185(Suppl 1):311-318. doi: 10.1093/milmed/usz260.